The Directory of Open Access Journals
DOAJ Logotype
Open
Global
Trusted
Main actions
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Search
Menu
Secondary actions
Search
Journals
Articles
Documentation
API
OAI-PMH
Widgets
Public data dump
OpenURL
XML
Metadata help
Preservation
About
About DOAJ
DOAJ at 20
DOAJ team
Ambassadors
Advisory Board & Council
Volunteers
News
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Login
Login
Quick search
Close
×
Journals
Articles
Search by keywords:
In the field:
In all fields
Title
ISSN
Subject
Publisher
Country of publisher
Search
ERJ Open Research
(May 2023)
Benefit−risk assessment of brensocatib for treatment of non-cystic fibrosis bronchiectasis
James D. Chalmers,
Mark L. Metersky,
Joseph Feliciano,
Carlos Fernandez,
Ariel Teper,
Andrea Maes,
Mariam Hassan,
Anjan Chatterjee
Affiliations
James D. Chalmers
Ninewells Hospital and Medical School, University of Dundee, Dundee, UK
Mark L. Metersky
University of Connecticut School of Medicine, Farmington, CT, USA
Joseph Feliciano
Insmed Incorporated, Bridgewater, NJ, USA
Carlos Fernandez
Insmed Incorporated, Bridgewater, NJ, USA
Ariel Teper
Insmed Incorporated, Bridgewater, NJ, USA
Andrea Maes
Insmed Incorporated, Bridgewater, NJ, USA
Mariam Hassan
Insmed Incorporated, Bridgewater, NJ, USA
Anjan Chatterjee
Insmed Incorporated, Bridgewater, NJ, USA
DOI
https://doi.org/10.1183/23120541.00695-2022
Journal volume & issue
Vol. 9, no. 3
Abstract
Read online
No abstracts available.
WeChat QR code
Close